Search
InspireMD Inc
NSPRAdd to Watchlist
0.751USD
-0.008-1.05%
Close 09-23 16:00（ET）
35.18MMarket Cap
LossP/E TTM
About InspireMD Inc Company
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
InspireMD Inc Profile
Ticker SymbolNSPR
Company nameInspireMD Inc
IPO dateApr 12, 2013
CEOSlosman (Marvin L)
Number of employees85
Security typeOrdinary Share
Fiscal year-endApr 12
Address6303 Waterford District Drive
CityMIAMI
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33126
Phone18887766804
Websitehttps://www.inspiremd.com/en/
Ticker SymbolNSPR
IPO dateApr 12, 2013
CEOSlosman (Marvin L)
Company Executives of InspireMD Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Andrea Tommasoli
Mr. Andrea Tommasoli
Chief Operating Officer
Chief Operating Officer
954.39K
--
Dr. Gary S. Roubin, M.D., Ph.D.
Dr. Gary S. Roubin, M.D., Ph.D.
Independent Director
Independent Director
834.48K
+10.79%
Dr. Gary S. Roubin, M.D., Ph.D.
Dr. Gary S. Roubin, M.D., Ph.D.
Independent Director
Independent Director
834.48K
+10.79%
Dr. Gary S. Roubin, M.D., Ph.D.
Dr. Gary S. Roubin, M.D., Ph.D.
Independent Director
Independent Director
834.48K
+10.79%
Mr. Michael Berman
Mr. Michael Berman
Independent Director
Independent Director
597.58K
+10.25%
Mr. Michael Berman
Mr. Michael Berman
Independent Director
Independent Director
597.58K
+10.25%
Mr. Michael Berman
Mr. Michael Berman
Independent Director
Independent Director
597.58K
+10.25%
Ms. Kathryn Arnold
Ms. Kathryn Arnold
Independent Director
Independent Director
303.09K
+18.33%
Mr. Danny L. (Dan) Dearen
Mr. Danny L. (Dan) Dearen
Independent Director
Independent Director
100.05K
-2.00%
Mr. Danny L. (Dan) Dearen
Mr. Danny L. (Dan) Dearen
Independent Director
Independent Director
100.05K
-2.00%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Andrea Tommasoli
Mr. Andrea Tommasoli
Chief Operating Officer
Chief Operating Officer
954.39K
--
Dr. Gary S. Roubin, M.D., Ph.D.
Dr. Gary S. Roubin, M.D., Ph.D.
Independent Director
Independent Director
834.48K
+10.79%
Dr. Gary S. Roubin, M.D., Ph.D.
Dr. Gary S. Roubin, M.D., Ph.D.
Independent Director
Independent Director
834.48K
+10.79%
Dr. Gary S. Roubin, M.D., Ph.D.
Dr. Gary S. Roubin, M.D., Ph.D.
Independent Director
Independent Director
834.48K
+10.79%
Mr. Michael Berman
Mr. Michael Berman
Independent Director
Independent Director
597.58K
+10.25%
Mr. Michael Berman
Mr. Michael Berman
Independent Director
Independent Director
597.58K
+10.25%
FAQs
Who are the top five shareholders of InspireMD Inc?
The top five shareholders of InspireMD Inc are: Mr. Andrea Tommasoli
How many institutions hold shares of InspireMD Inc (NSPR)?
As of 2026Q1, 67 institutions hold shares of InspireMD Inc, with a combined market value of approximately 23.13M, accounting for 49.38% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -455014.00.